Catalyst Repository | InVivo Therapeutics Holdings Corp Common Stock

InVivo Therapeutics Holdings Corp Common Stock

(NASDAQ:NVIV)

Description

InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). The company is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. InVivo Therapeutics Holdings Corp. was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.

NVIV Overview

None
Sector
Health Care
Industry
Medical/Dental Instruments

Previous Close
$1.3100
Previous Close Volume
8430